Owing to the antitumorigenic role of miR-1 in SCLC, our results suggest a novel mechanistic insight that miR-1 targets the CXCR4/FOXM1/RRM2 axis that attenuates SCLC growth and metastasis. The gene discussed is CXCR4; the disease is small cell lung carcinoma.